Intravenous Bisphosphonates for Postmenopausal Osteoporosis
Author Information
Author(s): Mottaghi Peyman
Primary Institution: Isfahan University of Medical Sciences
Hypothesis
This article proposed to review effectiveness and tolerability of intravenous BPs in postmenopausal women with osteoporosis.
Conclusion
Intravenous bisphosphonates are effective alternatives to oral bisphosphonates for treating postmenopausal osteoporosis, especially for those who cannot tolerate oral medications.
Supporting Evidence
- Intravenous bisphosphonates avoid gastrointestinal intolerance and complex dosing instructions.
- Intravenous therapy has gained a high degree of compliance among patients.
- Pamidronate and ibandronate have shown significant increases in bone density compared to oral alternatives.
Takeaway
This study shows that getting medicine through an IV can help women with weak bones feel better and avoid problems that come from taking pills.
Methodology
The article reviews various studies and clinical trials on the effectiveness and tolerability of intravenous bisphosphonates in postmenopausal women.
Potential Biases
Potential bias due to reliance on retrospective analyses and existing studies.
Limitations
The study primarily reviews existing literature and may not include all recent data or studies.
Participant Demographics
Postmenopausal women with osteoporosis.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website